Study on Boredom in High Potential Adolescents (ESchAHP)

March 8, 2024 updated by: Centre Psychothérapique de Nancy

Study on High Potential in Adolescence School Boredom as a Precursor to a Depressive Episode Single-center, Comparative Study of High School Students

The research focuses on "High Potential" (HP) in adolescence, in a link with the professional practice of the investigators.

Furthermore, supported by scientific literature and professional clinical practice, this research is interested in school boredom, regularly expressed by the consulting adolescents, in its relation with a depressive syndrome.

The objective of the research is to know if school boredom is a precursor of a depressive episode in high school students with HP compared to high school students without HP.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The investigators are questioning the meaning of school boredom experienced by adolescents with HP and its link with a depressive syndrome. The investigators will use clinical interviews, rating scales for a quantitative measure and projective tests for a psychodynamic study. The responses of adolescents with HP will be compared to those of adolescents without HP.

Study Type

Observational

Enrollment (Actual)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Lunéville, France
        • Centre Psychothérapique de Nancy - CMP Adolescents Lunéville

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 17 years (Child)

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Adolescents consulting the medical-psychological centers of our hospital (Centre Psychothérapique de Nancy = Sponsor) for psychological malaise and/or anxiety-depressive disorders and academic difficulties

Description

Inclusion Criteria:

  • Adolescents coming for consultation in a medical-psychological center of Sponsor
  • Adolescents aged 14 to 16 years and 11 months.
  • Adolescents expressing a psychological malaise and/or an anxiety disorder at the time of the consultation request
  • Adolescents who were informed about the study, received the information note about it and did not object to participating
  • At least one parent or guardian who was informed of the study, received the study information sheet, and did not object to the child's participation
  • Adolescents affiliated or entitled to a social security plan

Exclusion Criteria:

  • Adolescents who do not understand the French language well enough to complete the questionnaires.
  • Adolescents with a clear diagnosis of psychiatric pathology (e.g. schizophrenia)
  • Adolescents with an IQ ≤ 80 because the level of intellectual efficiency would be too fragile and too far from the expectations of our research.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Group gifted teens
intervention with adolescents through the presentation of questions to be completed
Group no gifted teens
intervention with adolescents through the presentation of questions to be completed

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Wechsler Intelligence Scale for Children
Time Frame: Month 2 or 3
Intelligence test that measures a child's intellectual ability and 5 cognitive domains that impact performance.
Month 2 or 3
Échelle de Disposition à l'Ennui (French Title)
Time Frame: Month 1 or 2
Boredom scale It is the French adaptation of the Boredom Proneness Scale
Month 1 or 2
Rorschach test
Time Frame: Month 3
Projective test
Month 3
Thematic Apperception Test
Time Frame: Month 3
Projective test
Month 3

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Multidimensional Anxiety Scale for Children
Time Frame: Month 1 or 2
Anxiety scale
Month 1 or 2
Children Depression Inventory
Time Frame: Month 1 or 2
Depression scale
Month 1 or 2
Self-Perception Profile for Adolescents
Time Frame: Month 1 or 2
Self-esteem scale This self-report scale taps how adolescents assess their "competence" or "adequacy" in different areas of their life, and how they evaluate their overall self-worth as a person.
Month 1 or 2

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Valérie BURGÉ, Centre Psychothérapique de Nancy

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2022

Primary Completion (Actual)

December 15, 2023

Study Completion (Actual)

December 15, 2023

Study Registration Dates

First Submitted

October 20, 2021

First Submitted That Met QC Criteria

October 20, 2021

First Posted (Actual)

October 28, 2021

Study Record Updates

Last Update Posted (Actual)

March 12, 2024

Last Update Submitted That Met QC Criteria

March 8, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • RIPH 2021-02
  • 2021-A01118-33 (Other Identifier: ANSM (French competent authority))

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Intelligence

Clinical Trials on psychodynamic

Subscribe